• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 39-53 of 6,071 results

No. 546 ORDER GRANTING MOTION FOR ADMISSION TO APPEAR PRO HAC VICE OF ALEXANDRA SCHRADER granting ...

Document Novartis Pharma AG v. Incyte Corporation, 1:20-cv-00400, No. 546 (S.D.N.Y. Mar. 28, 2025)
Motion to Appear Pro Hac ViceGranted
The motion of Alexandra Schrader (“Applicant”) for admission to practice pro hac vice in the above captioned action is granted.
All attorneys appearing before this Court are subject to the Local Rules of this Court, including the Rules governing discipline of attorneys.
United States Magistrate Judge
cite Cite Document

No. 215 MEMORANDUM AND ORDER granting in part and denying in part 207 Letter Motion to Seal

Document Adstra, LLC v. Kinesso, LLC et al, 1:24-cv-02639, No. 215 (S.D.N.Y. Mar. 31, 2025)
Motion to SealPartial
Defendants argue that for this set of documents, the presumption is overcome by the countervailing harm that would occur from the disclosure of confidential business information and trade secrets.
However, Defendants are correct that because motions for discovery and to preclude expert testimony are “ancillary to the court’s core role in adjudicating a case,” the weight of the presumption of public access to these documents is low.
paragraphs beginning “[i]n particular” in Appendix C are narrowly tailored to serve a strong countervailing interest in protecting confidential business information.
Adstra seeks to maintain under seal the same memoranda of law and statements of undisputed facts which Defendants have proposed to refile with limited redactions.
Defendants have already proposed refiling the legal documents with much more limited targeted redactions, which the Court has agreed are justified to protect Defendants’ confidential business information that has not already been disclosed in this litigation.
cite Cite Document

No. 205 CLERK'S JUDGMENT re: 203 Memorandum & Opinion in favor of Acxiom, LLC, Kinesso, LLC against ...

Document Adstra, LLC v. Kinesso, LLC et al, 1:24-cv-02639, No. 205 (S.D.N.Y. Feb. 27, 2025)
Motion for JudgmentGranted
It is hereby ORDERED, ADJUDGED AND DECREED: That for the reasons stated in the Court's Opinion and Order dated February 19, 2025, Defendants' motion for summary judgment, Dkt. No. 128, is GRANTED.
Plaintiff's motion for partial summary judgment, Dkt. No. 107, is DENIED.
Plaintiff's motion for reconsideration, Dkt. No. 88, is DENIED.
Defendants' motion to dismiss, Dkt. No. 44, Plaintiff's motion to preclude expert reports and testimony, Dkt. No. 133, Defendant's motions to preclude expert reports and testimony, Dkt. Nos. 117, 122, and Plaintiff's letter motion to compel unredaction, Dkt. No. 200, are DENIED as moot.
Judgment entered for Defendants, and the case is closed.
cite Cite Document

No. 521 ORDER: For the reasons stated on the record during the conference held on February 21, 2025, ...

Document Novartis Pharma AG v. Incyte Corporation, 1:20-cv-00400, No. 521 (S.D.N.Y. Feb. 21, 2025)
GREGORY H. WOODS, United States District Judge: For the reasons stated on the record during the conference held on February 21, 2025,
Defendant’s motion to compel the documents described in the parties’ February 12, 2025 letter in advance of its anticipated deposition of Mr. Peter Harwich is due by March 3, 2025.
Plaintiff’s opposition and counter-motion to compel, if any, is due by March 10, 2025.
Pursuant to the reference order in this case, Dkt. No. 102, the parties’ motions should be addressed to Judge Gorenstein.
United States District Judge
cite Cite Document

No. 204

Document Adstra, LLC v. Kinesso, LLC et al, 1:24-cv-02639, No. 204 (S.D.N.Y. Feb. 21, 2025)

cite Cite Document

No. 203

Document Adstra, LLC v. Kinesso, LLC et al, 1:24-cv-02639, No. 203 (S.D.N.Y. Feb. 19, 2025)

cite Cite Document

No. 513

Document Novartis Pharma AG v. Incyte Corporation, 1:20-cv-00400, No. 513 (S.D.N.Y. Feb. 13, 2025)

cite Cite Document

No. 504

Document Novartis Pharma AG v. Incyte Corporation, 1:20-cv-00400, No. 504 (S.D.N.Y. Feb. 10, 2025)

cite Cite Document

No. 1191

Document Syntel Sterling Best Shores Mauritius Limited v. The Trizetto Group, Inc. et al, 1:15-cv-00211, No. 1191 (S.D.N.Y. Feb. 10, 2025)

cite Cite Document

No. 478

Document Novartis Pharma AG v. Incyte Corporation, 1:20-cv-00400, No. 478 (S.D.N.Y. Jan. 31, 2025)

cite Cite Document

No. 472

Document Novartis Pharma AG v. Incyte Corporation, 1:20-cv-00400, No. 472 (S.D.N.Y. Dec. 27, 2024)

cite Cite Document

No. 470

Document Novartis Pharma AG v. Incyte Corporation, 1:20-cv-00400, No. 470 (S.D.N.Y. Dec. 26, 2024)

cite Cite Document

No. 1175

Document Syntel Sterling Best Shores Mauritius Limited v. The Trizetto Group, Inc. et al, 1:15-cv-00211, No. 1175 (S.D.N.Y. Dec. 5, 2024)

cite Cite Document

No. 1169

Document Syntel Sterling Best Shores Mauritius Limited v. The Trizetto Group, Inc. et al, 1:15-cv-00211, No. 1169 (S.D.N.Y. Nov. 13, 2024)

cite Cite Document

No. 84

Document Adstra, LLC v. Kinesso, LLC et al, 1:24-cv-02639, No. 84 (S.D.N.Y. Nov. 13, 2024)

cite Cite Document
<< 1 2 3 4 5 6 7 ... >>